Plenary Session II: Thursday, October 22, 2020

In this session, Dr. Jennifer Taylor-Cousar will highlight the latest research into highly effective CFTR modulators, providing an in-depth overview of the CFTR modulator research landscape one-year post-approval of Trikafta. She will describe the ongoing and upcoming studies looking at the holistic impact of highly effective CFTR modulation on the lives of people with CF. Finally, she will review on-going and upcoming studies for the development of new modulators as well as the potential impact of modulators on complications.